 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
 |
Pittsburgh, PA |
 |
09/23/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases |
 |
Stanford, CA |
 |
09/01/2009 |
 |
 |
 |
Details |
 |
A phase II trial of PTK-787 in recurrent or progressive meningiomas |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Trial for Patients with Recurrent Resectable Glioblastoma Multiforme Using Surgery with Implantable BCNU Polmer Followed by Post-operative Irinotecan and Bevacizumab |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
Details |
 |
RTOG 0614 A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
West Palm Beach, FL Charlotte, NC Durham, NC |
 |
06/16/2009 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Oceanside, NY |
 |
05/20/2009 |
 |
 |
 |
Details |
 |
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
 |
 |
Details |
 |
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma |
 |
Bethesda, MD |
 |
04/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Back up Stereotactic Radiation Therapy |
 |
Cincinnati, OH |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone |
 |
Cincinnati, OH |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase III double blind, placebo controlled study of donepezil in irradiated brain tumor patients |
 |
Houston, TX |
 |
04/03/2009 |
 |
 |
 |
Details |
 |
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
 |
Santa Monica, CA |
 |
11/29/2008 |
 |
 |
 |
 |
 |
Details |
 |
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
 |
Cleveland, OH Cleveland, OH |
 |
11/19/2008 |
 |
 |
 |
Details |
 |
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
 |
Houston, TX |
 |
10/27/2008 |
 |
 |
 |
 |
 |
Details |
 |
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors |
 |
Cleveland, OH |
 |
09/28/2008 |
 |
 |
 |
Details |
 |
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer |
 |
New York, NY Houston, TX San Antonio, TX |
 |
07/24/2008 |
 |
 |
 |
 |
 |
Details |
 |
Gliogene: An International Brain Tumor Study |
 |
Houston, TX |
 |
07/24/2008 |
 |
 |
 |
Details |
 |
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
 |
Los Angeles, CA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Kingston, Ontario, CANADA Edmonton, Alberta, CANADA Moncton, New Brunswick, CANADA Ottawa, Ontario, CANADA Toronto, Ontario, CANADA Winnipeg, Manitoba, CANADA Phoenix, AZ La Jolla, CA Palo Alto, CA Sacramento, CA Aurora, CO Englewood, CO Jacksonville, FL Orlando, FL Chicago, IL Evanston, IL Boston, MA Detroit, MI Winston-Salem, NC Edison, NJ Buffalo, NY Columbus, OH Columbus, OH Portland, OR Memphis, TN Nashville, TN Seattle, WA Madison, WI |
 |
03/01/2008 |
 |
 |
 |
Details |
 |
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
 |
NEW YORK CITY, NY |
 |
08/20/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms |
 |
New York, NY |
 |
08/20/2007 |
 |
 |
 |
Details |
 |
Identification of factors associated with brain metastasis in women with breast cancer: development of a predictive nomogram |
 |
Cleveland, OH |
 |
08/18/2007 |
 |
 |
 |
 |
 |